Navigation Links
Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
Date:6/3/2008

FRAZER, Pa., June 3 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that it and its wholly-owned subsidiary CIMA LABS INC. have filed a lawsuit in U.S. District Court in Delaware against Watson Pharmaceuticals, Inc. and its wholly-owned subsidiary, Watson Laboratories, Inc., for infringement of U.S. Patent Nos. 6,200,604 and 6,974,590, which cover methods of use for the Cephalon product FENTORA(R) (fentanyl buccal tablet) [C-II]. The 6,200,604 and 6,974,590 patents do not expire until 2019. FENTORA was approved by the U.S. Food and Drug Administration (FDA) in September 2006 for the management of breakthrough pain in patients with cancer who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

The lawsuit is based upon an Abbreviated New Drug Application (ANDA) filed by Watson seeking FDA approval for a generic equivalent of fentanyl buccal tablets to be sold in the United States. Watson alleges that the above two FENTORA patents are invalid, unenforceable and/or will not be infringed by Watson's manufacture, use or sale of the product described in its ANDA.

"We believe that the proposed Watson ANDA product infringes our patents," said Jerry Pappert, Executive Vice President and General Counsel. "The FENTORA patents were approved by the United States Patent and Trademark Office based on the results of extensive research by CIMA LABS. We continue to believe that our patent position for this product is strong and intend to vigorously defend our intellectual property."

The filing of this lawsuit is provided for by the Hatch-Waxman Act, a federal statute governing certain aspects of generic drug approvals. Under that statute, the filing of the lawsuit stays any FDA approval of the Watson ANDA until the earlier of a district court judgment in favor of Watson or 30 months from the company's April 2008 receipt of a Paragraph IV certification letter from Watson.

A
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...ill accelerate research of potential vaccine for l...HERSBURG, Md., Dec. 4 The biotech ...bal health organization PATH announced today a par...uenza vaccine. PATH will initially invest $3 milli...stage development of a H5N1 virus-like particle (V...
(Date:12/4/2008)... Md., Dec. 4 MedImmune today annou...al in patients with chronic asthma to,determine t...noclonal antibody,(MAb) that targets the interleu...that inhibiting the IL-5R pathway may lead to a ta..., supporting continued study of this antibody. , ...
(Date:12/4/2008)...USTIN, Calif., Dec. 4 ...today announced that it will release its financial...9 on December 10, 2008 at 7:00 a.m. EST and will h...esults at 11:30 a.m. EST on the same day. , ,...ancial results for the second quarter ended Octobe...
(Date:12/4/2008)... Trusted LASIK Surgeons launched its r...ice and website at www.TrustedLASIKSurgeons.com ...ng to improve their vision. What sets the Trusted ...ng process ensuring that only those who are among ...y in the United States are listed. Refractive eye...
Breaking Biology Technology:Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 2Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 3MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 2MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 3Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results 2Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 2Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 3Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 4Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 5Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 6Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 7
...e big enough that no one is likely to see everythi...es where they,ll be during the marathon event that...this April 9 through 12. Here,s a sampling of thei...e applied to present as part of the Business Forum...ting and opportunities for companies to meet with ...
...1,000 scholarships and a top prize of $7,500 in se... in a business-plan competition sponsored by BizF...he Young Entrepreneur Foundation . , ,The contest...from U.S. college and high-school students until M..., , Young Entrepreneur Foundation: Contest guidel...
...s Bio Corporation says its scientists have develo...ly. , ,Antibodies, naturally part of the immune sy...iseases and for diagnostics or research. Mirus, ne...oTechniques, involves intravenously injecting DNA ...ibodies that are harvested and used. , ,According ...
...nt Lawrence H. Summers created a firestorm last ye...ion in math and science fields might be the result... women. While that comment may be only part of the..., it focused the spotlight on the need for more di..., diversity in top IT positions has a way to go, b...
Other Biology Technology:Where will you be at BIO? 2Diversity still an elusive goal in IT, other tech fields 2Diversity still an elusive goal in IT, other tech fields 3
(Date:12/4/2008)...ech Wake Forest University,s School of Biomedical...chanics has received the Army Modeling and Simulat...Chief of Staff of the Army and Director of the Arm...mately help save eyesight and reduce morbidity and... center was selected from 57 applicants from aroun...
(Date:12/4/2008)... looking for bonefish from Miami down to the Marqu...m, and that is down slightly from the average of p...ion among those who are counting, researchers spec... of Marine and Atmospheric Science held the sixth ...n with the conservation group Bonefish & Tarpon Un...
(Date:12/4/2008)... carry weight in the thighs and backside have been...re and heart disease than apple-shaped people who ...trition researchers at Washington University Schoo...arisons don,t completely explain risk. , In two ...e the real key to insulin resistance, cholesterol ...
(Date:12/4/2008)...ated with higher levels of omega-3 fatty acids in ...ing of the European study IMMIDIET that will be pu...nal of Clinical Nutriti on, an official publicatio...eady available on line ( www.ajcn.org ). The stud...lic drinks. This effect could be ascribed to compo...
Breaking Biology News(10 mins):New dummy design and development wins US Department of Defense award 2Bonefish census reveals population holding steady 2Apple or pear shape is not main culprit to heart woes -- it's liver fat 2A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart 2A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart 3PPD Reports Fourth Quarter and Year End 2007 Financial Results 11214 1PPD Reports Fourth Quarter and Year End 2007 Financial Results 11214 2PPD Reports Fourth Quarter and Year End 2007 Financial Results 11214 3PPD Reports Fourth Quarter and Year End 2007 Financial Results 11214 4PPD Reports Fourth Quarter and Year End 2007 Financial Results 11214 5PPD Reports Fourth Quarter and Year End 2007 Financial Results 11214 6Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13 2008 11209 1Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13 2008 11209 2Exelixis Announces February 12 Webcast of Presentation at the 10th Annual BIO CEO and Investor Conference 3088 1New Report Offers Comprehensive Look at Mental Health in Minnesota 11205 1New Report Offers Comprehensive Look at Mental Health in Minnesota 11205 2
...d that our brains fend off distractions. If we are...al influences. If we are tired, we can no longer d...the brain selects incoming information to remember... and neutral information may enter. In the event o... , Test , Psychologists carry out a lot of...
...ks a form of blood cancer in mice by engineering a...rtening the ends of chromosomes, called telomeres.... the cell commits suicide as a means of protecting...Nathans chair of molecular biology and genetics at...onth at Cancer Cell, uncovers an alternate respons...
...agen have demonstrated that the spinal cord use ne...n. The discovery is featured in the current issue ...ising results consists of Professor Jørn Hounsgaar... Copenhagen, and Assistant Professor and PhD Aidas...p has shown that spinal neurons, during network ac...
...f millions of hours of work productivity this spri...ver symptoms, including sneezing, watery eyes and ...n hour of work per week during peak hay fever seas...seem small, consider that 20 to 50 million America...ay fever, or allergic rhinitis, said Sheryl Szeinb...
Other Biology News:Brain fends off distractions 2Short chromosomes put cancer cells in forced rest 2Hay fever can send work productivity down the drain 2Hay fever can send work productivity down the drain 3
Zymoclean Gel DNA Recovery Kit from Zymo Research
Collected from 8-12 week-old New Zealand or Californian rabbits.,Supplied in lyophilized form.
DeadEnd Fluorometric TUNEL System from Promega
Agarose overlays are commonly used in baculovirus plaque assays. Many commercial "DNA grade" agaroses either contain contaminants that are toxic to insect cells or lack the physical characteristics r
Biology Products: